The role of myocardial viability in contemporary cardiac practice

Abdelrahman Jamiel1,2, Mohamad Ebid3, Amjad M Ahmed3

  • 1King Abdulaziz Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard - Health Affairs, Department Mail Code: 1413, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia. abdujamiel@yahoo.com.

Insights

Assessing myocardial viability in patients with old myocardial infarction (OMI) is crucial for improving outcomes. Advanced imaging techniques help identify viable myocardium to optimize revascularization strategies.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Ischemic heart disease (IHD) is a leading cause of global mortality.
  • Ischemic cardiomyopathy, a consequence of coronary artery disease, significantly impacts patient outcomes.
  • Assessing viable myocardium (VM) in old myocardial infarction (OMI) patients is vital for predicting short- and long-term prognosis.

Purpose of the Study:

  • To provide a state-of-the-art review on assessing myocardial viability.
  • To highlight the importance of preoperative assessment of myocardial viability for guiding revascularization in OMI patients with left ventricular dysfunction.

Main Methods:

  • Review of existing observational data and non-invasive imaging techniques for assessing myocardial viability.
  • Focus on identifying viable but inadequately perfused myocardium.

Main Results:

  • Observational data suggest improved outcomes when revascularization is guided by viability assessment.
  • Current cardiovascular imaging faces challenges in precisely assessing myocardial viability.

Conclusions:

  • Accurate assessment of myocardial viability is essential for optimizing patient selection for coronary revascularization.
  • Further advancements in non-invasive imaging techniques are needed to improve the assessment of myocardial viability.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
673
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
702
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
408